Literature DB >> 15973009

Clinical characteristics of adult Escherichia coli meningitis.

Tzu-Ming Yang1, Cheng-Hsien Lu, Chi-Ren Huang, Hui-Hong Tsai, Nai-Wen Tsai, Ping-Yu Lee, Chun-Chih Chien, Wen-Neng Chang.   

Abstract

The clinical characteristics and therapeutic outcomes of adult meningitis due to Escherichia coli alone have not been examined adequately. In this study, we analyzed the clinical and laboratory data of 15 adult patients with monomicrobial E. coli meningitis. The 15 patients, collected over a period of 18 years (January 1986-December 2003), included 7 men and 8 women, aged 45-77 years. They accounted for 5% (15/306) of our adult bacterial meningitis with single pathogen infection. This study also revealed that a post-neurosurgical state is the most important factor predisposing adult patients to develop E. coli meningitis. In this study, all of the tested E. coli strains showed their susceptibility to imipenem and/or meropenem, however, E. coli strains that are not susceptible to third-generation cephalosporin have emerged since 2001. As to the therapeutic results of these 15 cases, all 4 patients without appropriate antibiotic treatment died and the other 11 patients with appropriate antibiotic treatment showed a mortality rate of 27%. The emergence of third-generation cephalosporin non-susceptible E. coli strains in adult bacterial meningitis, as shown in this study, has caused a therapeutic challenge in choosing initial empirical antibiotics for treating adult patients with post-neurosurgical meningitis. Our results emphasize that the timely use of appropriate antibiotics is essential for the management of this potentially fatal central nervous system infection. However, it should be noted that the number of cases examined in this study is too small to reach a therapeutic conclusion regarding adult E. coli meningitis, and further large-scale studies will be needed for this purpose.

Entities:  

Mesh:

Year:  2005        PMID: 15973009

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  5 in total

1.  Intraperitoneal prophylaxis with CpG oligodeoxynucleotides protects neutropenic mice against intracerebral Escherichia coli K1 infection.

Authors:  Sandra Ribes; Tanja Meister; Martina Ott; Sandra Redlich; Hana Janova; Uwe-Karsten Hanisch; Stefan Nessler; Roland Nau
Journal:  J Neuroinflammation       Date:  2014-01-23       Impact factor: 8.322

2.  Nosocomial Escherichia coli meningitis in adults: Report of four cases and literature review.

Authors:  Fahmi Yousef Khan; Mohammed Abukhattab; Deshmukh Anand
Journal:  J Neurosci Rural Pract       Date:  2013-07

3.  Neuroinvasive Infection from O117:K52:H-Escherichia coli following Acute Pyelonephritis.

Authors:  H Cromlin; H Rodriguez-Villalobos; A Deplano; T Duprez; P Hantson
Journal:  Case Rep Infect Dis       Date:  2017-11-26

4.  Use of staged molecular analysis to determine causes of unexplained central nervous system infections.

Authors:  Chien-Chin Hsu; Rafal Tokarz; Thomas Briese; Hung-Chin Tsai; Phenix-Lan Quan; W Ian Lipkin
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883

5.  Spontaneous Escherichia coli bacterial meningitis mimicking heatstroke in an adult.

Authors:  Kenichiro Ishida; Mitsuhiro Noborio; Masayuki Nakamura; Yohei Ieki; Taku Sogabe; Daikai Sadamitsu
Journal:  Clin Case Rep       Date:  2016-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.